References
- Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long-term prognosis of hepatitis C viirus infection in Japan. Gut 1993, SupphS: 13–16
- Di Bisceglie A M, Goodman Z D, Ishak K G, Hoofnagle J H, Melpolder J J, Alter H J. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatologv 1991; 14: 969–74
- Verbaan H, Widell A, Lindgren S, Lindmark B, Nordenfelt E, Eriksson S. Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period. J Int Med 1992; 232: 33–42
- Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88(2)240–3
- Haber M M, West A B, Haber A D, Reuben A. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995; 90: 1250–7
- Gabrielli G B, Corrocher R. Hepatic fibrosis and its serum markers: a review. Dig Dis Sci 1991; 9: 303–16
- Schuppan D, Stölzel U, Oesterling C, Somasundaram R. Serum assays for liver fibrosis. J Hepatol 1995; 22(Suppl 2)82–8
- Ueno T, Inuzuka S, Torimura T, Oohira H, Ko H, Obata K, et al. Significance of serum type-IV collagen levels in various liver diseases. Scand J Gastroenterol 1992; 27: 513–20
- Murawaki Y, Ikuta Y, Koda M, Yamada S, Kawasaki H. Comparison of serum 7S fragment of type IV collagen and serum central triplehclix of type collagen for assessment of liver fibrosis in patients with chronic viral hepatitis. J Hepatol 1996; 24: 148–54
- Annoni G, Cargnel A, Colombo M, Hahn E G. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis. J Hepatol 1986; 2: 379–88
- Torres-Salinas M, Pares A, Cabellen'a J, Jimenez W, Heredia D, Bruguera M, et al. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology 1986; 90: 1241–6
- Lotterer E, Gressner A M, Kropf J, Grobe E, von Knebel D, Bircher J. Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity. J Hepatol 1992; 14: 71–7
- Feizi T. Immunoglobulins in chronic liver disease. Gut 1968; 9: 193
- Tsianos E V, Di Bisceglie A M, Papadopoulos N M, Costello R, Hoofnagle J H. Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis. Am J Gastroenterol 1990; 85(8)1005–8
- Obata K-I, Iwata K, Ichida T, Inoue K, Matsumoto E, Muragaki Y, et al. One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Clin Chim Acta 1989; 181: 293–304
- De Groote J, Desmet V J, Gedigk P. A classification of chronic hepatitis. Lancet 1968; 2: 626–8
- Knodell R G, Ishak K G, Black E C, Chen T S, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–5
- Scheuer P J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372–4
- Alter M J, Margolis H S, Krawczynski K, Judson F N, Mares A, Alexander W J, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899–905
- Yousef M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol 1992; 27: 812–6
- Lau J YN, Davis G L, Kniffen J, Qian K P, Urdea M S, Chan C S, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501–4
- Matsumoto Y, Muragaki Y, Ooshima A. Increased amount of serum type IV collagen peptide in human liver fibrosis as determined by enzyme-immunoassay with monoclonal antibodies. Acta Pathol Jpn 1989; 39: 217–23
- Trinchet J-C. Clinical use of serum markers of fibrosis in chronic hepatitis. J Hepatol 1995; 22(Suppl 2)89–95
- Matsuzaki Y, Yoshiga S, Sugitani T, Shoda J, Tanaka N, Osuga T. Enzyme immunoassay of serum type IV collagen in anti-HCV positive chronic liver diseases. Clin Chim Acta 1993; 221: 209–17
- Jeffers L J, Coelho-Little M E, Cheinquer H, Vargas C, Civantos F, Alvarez L, et al. Procollagen-III peptide and chronic viral C hepatitis. Am J Gastroenterol 1995; 90(9)1437–40